Combination of Gemcitabine and Cisplatin for Patients with Advanced Non-small-cell Lung Cancer
Objective To evaluate the curative effect and adverse reactions of combination of gemcitabine and cisplatin for patients with advanced non-small-cell lung cancer(NSCLC).Methods 27 patients with advance NSCLC were treated with this chemotherapy regimen.1 000 mg/m2 gemcitabine was given at 1st and 8th day and 20 mg/m2 Cisplatin were given from 1st to 4th days.The chemotherapy was repeated every 21 days on two or three cycles.Results Among these 27 patients,the overall response rate(CR+PR)was 40.7%.The main adverse reactions were myelosuppression,nausea and vomiting.Conclusions Gemcitabine combined with Cisplatin is an effective treatment for patients with advance NSCLC and adverse reactions is acceptable.
In the short paper we report the results of a workshop on the feasibility to carried out a brief counselling on smoking cessation and physical activity to female smokers attending the Italian National Health System Cervical Cancer Screening Program. The considerations derived from the midwives' experience during the recruitment of women for the SPRINT study, an intervention trial designed in order to verify the effectiveness of a standard counselling intervention on smoking cessation delivered by trained midwives in a gender-specific setting, the outpatient cervical cancer screening visits.